Atrial Septal Defect (ASD) Treatment in India & UAE

ASD treatment in India from $3,500. Catheter-based and surgical closure of atrial septal defect at Apollo, Medanta, Fortis. 98% success. Expert cardiologists and surgeons. Book a free consultation.

Estimated cost: $3,500 – $7,000 · Average stay: 2–5 days

An atrial septal defect (ASD) is a hole in the interatrial septum — the wall separating the right and left upper chambers (atria) of the heart. It is one of the most common congenital heart defects, detected in approximately 1 per 1,500 live births, and also commonly diagnosed for the first time in adults when investigated for unexplained atrial fibrillation, breathlessness, or right heart dilation. ASDs allow oxygenated blood from the high-pressure left atrium to flow through the defect into the lower-pressure right atrium — a left-to-right shunt that over time causes right heart enlargement, pulmonary hypertension, atrial arrhythmias, and paradoxical embolism (blood clots passing from the venous circulation through the ASD into the arterial circulation, causing stroke).

The vast majority of clinically significant ASDs are of the secundum type — located in the central fossa ovalis region of the atrial septum. These are ideally suited for catheter-based closure using an occluder device (most commonly the Amplatzer Septal Occluder or its equivalents), avoiding surgery entirely. Catheter closure is a same-day or next-morning procedure — a catheter is introduced via the femoral vein, the device is delivered across the ASD under fluoroscopic and echocardiographic guidance, and the double-disc occluder expands to seal the defect from both sides. The device becomes covered with cardiac tissue (endothelialized) within 3–6 months, achieving complete closure.

India leads Asia in the volume of transcatheter ASD closures performed. Apollo Hospitals, Fortis Escorts Heart Institute, Medanta – The Medicity, Narayana Institute of Cardiac Sciences, and Sri Jayadeva Institute collectively perform thousands of ASD closures annually, with outcomes that match international standards. The cost of transcatheter ASD closure in India — $3,500–$6,000 including the Amplatzer device — compares with $15,000–$30,000 in the United States. For ASDs not suitable for catheter closure (primum ASD, sinus venosus ASD, large secundum ASD with inadequate rim) — surgical repair with a pericardial patch under cardiopulmonary bypass is performed at $3,500–$6,500.

Types of ASD and When Do They Need Treatment?

ASD Types by Location:

Secundum ASD (70% of ASDs): Hole in the fossa ovalis (central part of the atrial septum). The most common type; ideal for catheter-based closure when sufficient tissue rim (greater than 5 mm) exists around the defect to anchor the device. Large secundum ASDs (above 25–30 mm) may require surgical closure.

Primum ASD (15–20%): Located low in the septum, adjacent to the atrioventricular valves. Often associated with a cleft in the anterior leaflet of the mitral valve (partial AVSD — atrioventricular septal defect). Cannot be closed with a catheter device — requires surgical repair with simultaneous mitral cleft repair.

Sinus Venosus ASD (5–10%): Located near the entry of the superior or inferior vena cava, usually associated with partial anomalous pulmonary venous drainage (the right upper pulmonary veins drain to the superior vena cava or right atrium rather than the left atrium). Requires surgical repair — often complex (Warden procedure for superior sinus venosus ASD). Not suitable for catheter closure.

Coronary Sinus ASD (rare): Unroofing of the coronary sinus allows communication between the coronary sinus and the left atrium. Surgical repair required.

Patent Foramen Ovale (PFO): A flap-like incomplete fusion of the fossa ovalis present in 25–30% of adults — usually of no consequence but associated with paradoxical embolism causing cryptogenic stroke in some patients. PFO closure with an occluder device is offered for cryptogenic stroke in patients under 60 with a significant PFO (substantial right-to-left shunt on bubble echo or TEE).

Small ASDs (under 5–8 mm with small shunt and normal right heart size) can be observed with annual echocardiography — many have minimal haemodynamic impact and do not require closure.

Who Needs ASD Closure?

ASD closure is recommended when: the ASD causes significant left-to-right shunting (Qp:Qs above 1.5); right atrial or right ventricular enlargement is present on echo (indicating chronic volume overload); symptoms are present (breathlessness, reduced exercise tolerance, palpitations from AF or flutter); or paradoxical embolism has occurred (stroke or TIA).

The optimal age for elective closure is early childhood (1–3 years), allowing right heart remodeling before irreversible changes develop. In adults, closure is still recommended for hemodynamically significant defects — even in older patients (up to 70+ years), closure prevents further right ventricular dilation, reduces atrial fibrillation risk, and improves symptoms.

Contraindications to closure include: irreversible severe pulmonary hypertension (Eisenmenger syndrome — where the patient is dependent on the right-to-left shunt through the ASD); severe right ventricular dysfunction where the RV is dependent on the ASD as a pop-off valve; and anatomical features making device closure hazardous (inadequate rim around the ASD for device anchoring, proximity to the AV valves or pulmonary veins).

ASD Closure Procedures

Transcatheter Amplatzer Device Closure (for suitable secundum ASDs):

Under general anesthesia or deep sedation (trans-esophageal echocardiography is performed simultaneously for guidance), a femoral vein sheath is placed. A catheter is advanced through the femoral vein, inferior vena cava, right atrium, and across the ASD into the left atrium. A sizing balloon may be used to measure the stretched diameter of the defect (or 3D TEE provides precise sizing). The appropriate-diameter Amplatzer Septal Occluder (or equivalent — Figulla, Gore Cardioform) is loaded onto the delivery cable and advanced to the left atrium. The left disc is expanded in the left atrium and withdrawn against the left atrial side of the septum; the right disc is then expanded against the right atrial side — the two discs "sandwich" the atrial septum and close the defect. Device position and residual flow are confirmed by TEE before final release. The procedure takes 60–90 minutes.

Surgical ASD Closure (for primum, sinus venosus, large secundum, or failed catheter closure):

Median sternotomy or right mini-thoracotomy. Cardiopulmonary bypass. Right atriotomy (right atrium opened). The ASD is closed with a pericardial patch sutured to the margins of the defect under direct vision. Primum ASD: mitral cleft repair simultaneously. Sinus venosus ASD: Warden or redirection procedure to re-route the anomalous pulmonary veins to the left atrium. TEE confirms complete closure.

Procedure Steps

1. Pre-procedure: transthoracic echo (ASD size, rim assessment, pulmonary-to-systemic flow ratio Qp:Qs, pulmonary artery pressure); TEE for precise rim measurement and suitability for device closure; bubble contrast echo to assess right-to-left shunting.
2. Transcatheter closure: general anesthesia; TEE guidance; femoral vein access; catheter advanced to left atrium via ASD.
3. Device sizing: balloon sizing or 3D TEE measurement; device selected (typically 1–2 mm larger than stretched diameter).
4. Device deployment: left disc in left atrium; right disc in right atrium; TEE confirms position, device stability, no impingement on AV valves or pulmonary veins, no residual shunt.
5. Release: device released; final TEE assessment; sheath removed; groin compressed.
6. Recovery: 4–6 hours observation; echo before discharge; aspirin 75–150 mg for 6 months (device endothelialization period).
7. Surgical closure (if needed): standard CPB; right atriotomy; patch closure with glutaraldehyde-treated pericardium or Dacron; TEE confirmation.
8. Follow-up: echo at 1 month and 6 months to confirm device position and complete closure.

Cost Comparison Worldwide

Country — Range — Savings

--- — --- — ---

United States — $15,000 – $30,000 — Baseline

United Kingdom — $8,000 – $18,000 — ~45% savings vs. USA

India — $3,500 – $6,500 — Up to 78% savings vs. USA

UAE — $7,000 – $15,000 — ~55% savings vs. USA

Transcatheter ASD closure packages in India include: interventional cardiologist fee, catheterization laboratory charges, Amplatzer Septal Occluder device (the most significant cost item — international brand), TEE guidance, anesthesia, and 1–2 night hospital stay. Surgical ASD repair packages include: cardiac surgery, CPB, pericardial patch, ICU (1–2 days), ward (3–5 days), and post-operative echo. Gaf Healthcare obtains device-specific quotes to ensure the internationally certified Amplatzer device is used.

Recovery & Follow-up

Transcatheter ASD closure recovery is very fast: 4–6 hours observation after the procedure; discharge next morning or even same evening. Activities resume immediately; light sport at 2 weeks; full sport at 4–6 weeks. Aspirin 75–150 mg for 6 months is prescribed to prevent device thrombosis during endothelialization.

Surgical ASD repair: standard open-heart recovery — ICU 1–2 days; ward 4–5 days; sternal healing 6–8 weeks; full activity at 8–10 weeks.

Echo at 1 month confirms device position. Echo at 6 months confirms complete closure (endothelialization complete). After confirmed complete closure, antibiotic prophylaxis is no longer required after 6 months. Annual echocardiography thereafter monitors right ventricular remodeling (RV should progressively decrease in size as volume overload is relieved).

Recovery Tips

• Take aspirin as prescribed for 6 months — prevents device thrombosis during tissue ingrowth.
• Avoid contact sports and strenuous activity for 4–6 weeks after device closure.
• Antibiotic prophylaxis before dental procedures for 6 months after device closure; not required after confirmed complete closure.
• Attend the 1-month and 6-month echocardiograms — confirms device position and complete closure.
• Notify all future cardiologists, anesthesiologists, and dentists about your ASD closure device.
• MRI safety: Amplatzer devices are MRI-conditional — an MRI can be performed safely at most standard field strengths at 6 weeks after implantation. Always confirm with the MRI center.

Risks & Complications

Transcatheter ASD closure is extremely safe. Complications are rare: device embolization to the aorta or pulmonary artery (less than 0.5% — retrieved by catheter); erosion through the aortic root or atrial wall (0.1–0.3% — rare late complication requiring emergency surgery); complete heart block (rare — under 0.1%); thrombus formation on the device before endothelialization (prevented by antiplatelet therapy); and residual shunt (5–10%, usually small and clinically insignificant, often close spontaneously within 6 months). Surgical ASD repair risks include the standard open-heart risks (arrhythmia, bleeding, stroke, infection) at their lowest ranges for isolated ASD closure.

Why GAF Healthcare

Gaf Healthcare coordinates ASD closure for patients across all age groups — from infants and children needing elective repair to adults with symptomatic ASD or paradoxical stroke. We review the echocardiographic data and assess catheter closure suitability (rim adequacy, defect size, Qp:Qs) before recommending device closure versus surgical repair. Our coordinators arrange the procedure, confirm that the internationally certified Amplatzer device is used, and facilitate post-closure echocardiographic follow-up before the patient travels home.

Frequently Asked Questions

Does ASD always need to be closed?

Small ASDs (under 5–8 mm) with minimal shunting and normal right heart size may be observed without closure, as their haemodynamic impact is minimal. Moderate to large ASDs (causing right heart enlargement, Qp:Qs above 1.5, symptoms, or associated with AF) require closure to prevent progressive right heart dilation, pulmonary hypertension, and arrhythmias.

Is catheter ASD closure better than surgery?

For suitable secundum ASDs, catheter closure with an Amplatzer device is preferred — it avoids surgery and sternotomy, is done under sedation without general anesthesia in many centers, allows same-day discharge, and has equivalent long-term closure rates to surgery. Primum and sinus venosus ASDs are not suitable for catheter closure and require surgical repair.

What is an Amplatzer device?

The Amplatzer Septal Occluder (ASO) is a double-disc nitinol mesh device that is delivered through a catheter, expanded to close the ASD, and permanently implanted. Cardiac tissue grows over both discs within 3–6 months, permanently sealing the defect. The device remains in place for life, is MRI-conditional, and does not require removal.

What is the cost of ASD closure in India?

Transcatheter ASD closure (Amplatzer device) costs $3,500–$6,000 in India all-inclusive. Surgical ASD repair costs $3,500–$6,500. Compare with $15,000–$30,000 in the USA.